Pandora A/S
Major shareholder announcement
Major shareholder announcement
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that Parvus Asset Management Jersey Limited has notified the company that its subsidiary, Parvus European Opportunities Master Fund, now holds 3,967,640 shares, corresponding to 5.02% of the total voting rights and share capital.
In total, Parvus Asset Management Jersey Limited controls 12.50% of the voting rights and share capital in Pandora A/S.
ABOUT PANDORA
Pandora is the world's largest jewellery brand, specialising in the design, crafting and marketing of accessible luxury jewellery made from high-quality materials. Each piece is created to inspire self-expression, allowing people to share their stories and passions through meaningful jewellery. Pandora jewellery is sold in more than 100 countries through 6,800 points of sale, including more than 2,700 concept stores.
Headquartered in Copenhagen, Denmark, Pandora employs 37,000 people worldwide and crafts its jewellery using only recycled silver and gold. Pandora is committed to leadership in sustainability and has set out to halve greenhouse gas emissions across its value chain by 2030. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated revenue of DKK 31.7 billion (EUR 4.2 billion) in 2024.
CONTACT
For more information, please contact:
| Investor Relations BILAL AZIZ SVP, Investor Relations & Treasury +45 3137 9486 biazi@pandora.net ADAM FUGLSANG Director, Investor Relations +45 6167 7425 adfug@pandora.net | Corporate Communications JOHAN MELCHIOR VP, Media Relations & Public Affairs +45 4060 1415 jome@pandora.net |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Verkkokauppa.com Oyj18.11.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 18 November 2025
Aspo Plc18.11.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 18.11.2025
Genmab A/S18.11.2025 17:30:00 CET | Press release
Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma
SoftServe, Inc18.11.2025 17:01:00 CET | Press release
Partner Business Unit Marks Next Era of SoftServe–Microsoft Collaboration, Driving AI Impact Across Enterprises
Denodo Technologies Inc. (“Denodo”)18.11.2025 16:02:47 CET | Press release
Denodo Named “One to Watch” in Snowflake’s 2026 Modern Marketing Data Stack Report: How Marketers Become Agents of Change in an AI-Driven World
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom